Cas 851317-53-8,Carbamic acid, [(1S)-3-methyl-1-[(3-pyrrolidinylamino)carbonyl]butyl]-, phenylmethyl ester

851317-53-8

Post Buying Request

Basic information

Product Name: Carbamic acid, [(1S)-3-methyl-1-[(3-pyrrolidinylamino)carbonyl]butyl]-, phenylmethyl ester
Synonyms:
CAS NO:851317-53-8
Molecular Formula: C18H27N3O3
Molecular Weight: 333.431
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbamic acid, [(1S)-3-methyl-1-[(3-pyrrolidinylamino)carbonyl]butyl]-, phenylmethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbamic acid, [(1S)-3-methyl-1-[(3-pyrrolidinylamino)carbonyl]butyl]-, phenylmethyl ester(851317-53-8)
EPA Substance Registry System: Carbamic acid, [(1S)-3-methyl-1-[(3-pyrrolidinylamino)carbonyl]butyl]-, phenylmethyl ester(851317-53-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 851317-53-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

851317-53-8 Suppliers

Recommended suppliers

851317-53-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 851317-53-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,3,1 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 851317-53:
(8*8)+(7*5)+(6*1)+(5*3)+(4*1)+(3*7)+(2*5)+(1*3)=158
158 % 10 = 8
So 851317-53-8 is a valid CAS Registry Number.

851317-53-8Upstream product

851317-53-8Downstream Products

851317-53-8Relevant academic research and scientific papers

Novel and potent cyclic cyanamide-based cathepsin K inhibitors

Deaton, David N.,Hassell, Anne M.,McFadyen, Robert B.,Miller, Aaron B.,Miller, Larry R.,Shewchuk, Lisa M.,Tavares, Francis X.,Willard Jr., Derril H.,Wright, Lois L.

, p. 1815 - 1819 (2007/10/03)

Starting from a PDE IV inhibitor hit derived from high throughput screening of the compound collection, a key pyrrolidine cyanamide pharmacophore was identified. Modifications of the pyrrolidine ring produced enhancements in cathepsin K inhibition. An X-r

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 851317-53-8